Download Files:
Products Details
Product Description
– GIP/GLP-1 dual receptor agonist-1 (compound 4) is a GIP/GLP-1 receptor agonist. GIP/GLP-1 dual receptor agonist-1 can be used in the research of metabolic disorders and fatty liver diseases, including nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD)[1].
Web ID
– HY-153476
Shipping
– Room temperature
Molecular Formula
– N/A
References
– [1]Brian Lian, et al. Compositions and methods for the treatment of metabolic and liver disorders. WO2022159395.
CAS Number
– 2807481-02-1
Molecular Weight
– N/A
SMILES
– [Q-A-I-K-D-L-Aib -I-S-Y-D-S-T-F-T-G-E-Aib- Y]N[C@@H](CCCCNC(COCCOCCNC(COCCOCCNC(CC[C@H](NC(CCCCCP(O)(O)=O)=O)C(O)=O)=O)=O)=O)C([A-F-V-Q-W-L-I-A-G-G-P-S-S-G-A-P-P-P-S-NH2])=O.[14]
Clinical Information
– No Development Reported
Research Area
– Metabolic Disease
Solubility
– 10 mM in DMSO
Target
– GCGR
Pathway
– GPCR/G Protein
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
